<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>14</Volume>
				<Issue>12</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Sleep Duration and Cancer Risk: a Systematic Review and Meta-analysis of Prospective Studies</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>7509</FirstPage>
			<LastPage>7515</LastPage>
			<ELocationID EIdType="pii">28502</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>To assess the risk of cancers associated with sleep duration using meta-analysis of published cohort studies,we performed a comprehensive search using PubMed, Embase and Web of Science through October 2013.We combined hazard ratios (HRs) from individual studies using meta-analysis approaches. A random effectdose-response analysis was used to evaluate the relationship between sleep duration and cancer risk. Subgroupanalyses and sensitivity analyses were also performed. Publication bias was evaluated using Funnel plots andBegg’s test. A total of 13 cohorts from 12 studies were included in this meta-analysis, which included 723, 337participants with 15, 156 reported cancer outcomes during a follow-up period ranging from 7.5 to 22 years.The pooled adjusted HRs were 1.06 (95% CI: 0.92, 1.23; P for heterogeneity =0.003) for short sleep duration,0.91 (95% CI: 0.78, 1.07; P for heterogeneity &lt;0.0001) for long sleep duration. In subgroup analyses stratifiedby cancer type, long duration of sleep showed an inverse relation with hormone-related cancer (HR=0.79; 95%CI: 0.65, 0.97; P for heterogeneity =0.009) and a greater risk of colorectal cancer (HR=1.29; 95% CI: 1.09, 1.52;P for heterogeneity =0.346). Further meta-analysis on dose-response relationships showed that the relative risksof cancer were 1.00 (95% CI: 0.99, 1.01; P for linear trend=0.9151) for one hour of sleep increment per day, and1.00 (95% CI: 0.98, 1.01; P for linear trend=0.7749) for one hour of sleep increment per night. No significantdose-response relationship between sleep duration and cancer was found on non-linearity testing (P=0.5053). Ourmeta-analysis suggests a positive association between long sleep duration and colorectal cancer, and an inverseassociation with incidence of hormone related cancers like those in the breast. Studies with larger sample size,longer follow-up times, more cancer types and detailed measure of sleep duration are warranted to confirmthese results.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Sleep Duration</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cancer risk</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta-analysis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">hormone-related cancers</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28502_cf35dcc32cc44d3f38f838abcc4bca07.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
